Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Operating expenses:        
Research and development $ 9,341 $ 7,148 $ 18,627 $ 14,605
General and administrative 3,668 2,705 7,430 5,726
Total operating expenses 13,009 9,853 26,057 20,331
Loss from operations (13,009) (9,853) (26,057) (20,331)
Interest income 47 353 101 819
Net loss $ (12,962) $ (9,500) $ (25,956) $ (19,512)
Net loss per common share, basic and diluted $ (0.25) $ (0.22) $ (0.50) $ (0.51)
Weighted-average shares used to compute net loss per common share, basic and diluted 51,904,701 42,936,991 51,483,709 37,902,294